Planning for Commercial Success in Bio/BioConvergence March 2, 2007

You often have brilliant ideas about new or improved products, but ultimately it is the customer who decides whether your product is valuable or not. Planning for commercial success starts at the research stage and parallels the entire R&D process. During this session, experts will discuss how to:
- Establish scientific rationale
- Articulate unmet need
- Ensure appropriate diagnosis and treatment evaluation
- Position your product
- Ensure value proposition
- Ensure product access

The roundtable discussion format is interactive and informal and intended to be a conversation more than a presentation. So bring your questions with you!

Moderator
Scott M. Iyama, Corporate Associate, Member of the Emerging Companies Group, Orrick, Herrington & Sutcliffe LLP

Panelists
Dr. Chris Boerner, Group Product Manager, Xolair Marketing, Genentech Inc.
Sean McCarthy, D.Phil., MBA, Principal, Pappas Ventures
Martin Babler, former Vice President of Immunology Sales and Marketing at Genentech, Inc.
Jaisim Shah, Senior Vice President, Marketing and Business Affairs, PDL BioPharma

Agenda
3:00-3:30 PM Networking & Registration
3:30-5:00 PM Expert Panel
5:00-6:30 PM Networking Reception

About San Jose BioCenter:
The San Jose BioCenter features state of the art lab and business space, a brand new Chemistry Analytics Lab and world class business development services for high potential bioscience companies.
The goal of the San Jose BioCenter is to advance technology for societal benefit and to catalyze economic development for community growth.

Regular Price ~ $25 ; Partners' Network ~ $15; SJBC members ~ Free; Door Registration: add $5 to these fees.

Email: [email protected]
Phone: 408-960-3807

Official Website: http://www.sjbiocenter.com/ev_industry-roundtable.html